SynthSense couples generative molecular AI with retrosynthetic reward functions to produce novel, drug-like molecules that are not only feasible to synthesize but aligned with the parallel synthesis workflows of modern medicinal chemistry.
Dekleva et al. (Thu,) studied this question.